Ginkgo Bioworks Holdings Inc (NYSE:DNA)
$ 9.66 -0.56 (-5.48%) Market Cap: 587.43 Mil Enterprise Value: 367.95 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 37/100

Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 07:15PM GMT
Release Date Price: $68 (+10.39%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at JPMorgan. I'm joined by Jason Kelly from the Ginkgo team. And so today is going to be a 40-minute presentation. Jason is going to start off with some slides, followed by about 20 minutes of Q&A.

(Operator Instructions) And for those of you in the room, please raise your hand. We have mic runners throughout. I just ask that please don't ask your question until we have the mic in your hand, so we can all hear you.

And with that, Jason.

Jason Kelly
Ginkgo Bioworks Holdings, Inc. - Founder, CEO & Director

All right. Well, thanks. Jason Kelly, I'm one of the Co-Founders and CEO here at Ginkgo. I want to start by thanking JPMorgan for getting us all back together this year. It's actually -- I'm sure it was not easy to reboot this after a couple of years off, and it's really nice to see everyone.

Okay. So I'm going to kind of cover 3 topics today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot